Conference on Feasibility of Genetic Technology to Close the HIV Window in Donor Screening; Notice of Public Meeting

Streszczenie

The Food and Drug Administration (FDA), Office of the Commissioner, is sponsoring a public meeting to evaluate the feasibility and utility of gene amplification techniques to enhance viral detection in the seronegative ``window'' phase of human immunodeficiency virus (HIV) infection. DATES: The public meeting will be held on Monday, September 26, 1994, 7 a.m. to 4 p.m. through Wednesday, September 28, l994, 12 m.